Immunosenescence and vaccine failure in the elderly
The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Abstract
An age-related decline in immune responses in the elderly results in greater susceptibility to infection and reduced responses to vaccination. This decline in immune function affects both innate and adaptive immune systems. A meeting of experts in immunology and gerontology in Paris, France, in April 2008, considered current understanding of immunosenescence and its clinical consequences. Essential features of immunosenescence include: reduced natural killer cell cytotoxicity on a per cell basis; reduced number and function of dendritic cells in blood; decreased pools of naive T and B cells; and increases in the number of memory and effector T and B cells. In particular, an accumulation of late differentiated effector T cells, commonly associated with cytomegalovirus infection, contributes to a decline in the capacity of the adaptive immune system to respond to novel antigens. Consequently, vaccine responsiveness is compromised in the elderly, especially frail patients. Strategies to address the effects of immunosenescence include ensuring that seroprotective antibody levels against preventable infectious diseases are maintained throughout adulthood, and improving diet and exercise to address the effects of frailty. New vaccines are being developed, such as intradermal and high-dose vaccines for influenza, to improve the efficacy of immunization in the elderly. In the future, the development and use of markers of immunosenescence to identify patients who may have impaired responses to vaccination, as well as the use of end-points other than antibody titers to assess vaccine efficacy, may help to reduce morbidity and mortality due to infections in the elderly.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, decreased proliferative activity of T cells after vaccination will reduce vaccine efficacy that is known to be suboptimal in older subjects [6].”
From Senescence of T Lymphocytes: Implications for Enhancing Human Immunity (2016) · cites this paper as [6]
In the citing paper
“Immunity declines during ageing and this is highlighted by the increased susceptibility to infection induced by previously encountered [1, 2] as well as new emerging pathogens [3-5] and also decreased ability to respond to vaccination [6].”
From Senescence of T Lymphocytes: Implications for Enhancing Human Immunity (2016) · cites this paper as [6]
In the citing paper
“The efficacy of many vaccines is reduced in older subjects [6]”
From Senescence of T Lymphocytes: Implications for Enhancing Human Immunity (2016) · cites this paper as [6]
In the citing paper
“On one hand, there is evidence of aging-associated deterioration of the adaptive immune system that affects T-cell and B-cell functions (Gibson et al, 2009;Grubeck-Loebenstein et al, 2009).”
From Microglia Priming with Aging and Stress (2017) · cites this paper as Grubeck-Loebenstein et al, 2009
In the citing paper
“These changes are attributed to aging-associated immune senescence that impairs the ability to fight infections and produce antibodies critical for the efficacy of vaccines (Grubeck-Loebenstein et al, 2009).”
From Microglia Priming with Aging and Stress (2017) · cites this paper as Grubeck-Loebenstein et al, 2009
Citations
Cites
1 retracted
Chandra, R. K. (2002) · Nutrition Research · doi:10.1016/s0271-5317(01)00366-9 · Cited by 26
RetractedFrailty in Older Adults: Evidence for a Phenotype
Fried, L. P., Tangen, C. M., Walston, J., Newman, A. B., Hirsch, C., Gottdiener, J., Seeman, T., Tracy, R., Kop, W. J., Burke, G., et al. (2001) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/56.3.m146 · Cited by 24,907
Inflamm‐aging: An Evolutionary Perspective on Immunosenescence
FRANCESCHI, C., BONAFÈ, M., VALENSIN, S., OLIVIERI, F., DE LUCA, M., OTTAVIANI, E., & DE BENEDICTIS, G. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06651.x · Cited by 5,358 · cited 1×
“This progressive proinflammatory state in elderly persons has been called ‘inflamm-aging’ (22).”
BackgroundIPC: Professional Type 1 Interferon-Producing Cells and Plasmacytoid Dendritic Cell Precursors
Liu, Y.-J. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115633 · Cited by 1,625
Phenotype of frailty: characterization in the women's health and aging studies
Bandeen-Roche, K., Xue, Q.-L., Ferrucci, L., Walston, J., Guralnik, J. M., Chaves, P., Zeger, S. L., & Fried, L. P. (2006) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/61.3.262 · Cited by 1,215 · cited 1×
“In recent years, there has been growing recognition of a ‘frailty phenotype’ in the aging population, which is manifested in unintentional weight loss, exhaustion, weakness, slow walking speed and low physical activity, and is associated with the risk of institutionalization and mortality (59, 60) and of impaired immu…”
BackgroundSteady-state and inflammatory dendritic-cell development
Shortman, K., & Naik, S. H. (2007) · Nature Reviews Immunology · doi:10.1038/nri1996 · Cited by 1,190
Antibody response to influenza vaccination in the elderly: A quantitative review
GOODWIN, K., VIBOUD, C., & SIMONSEN, L. (2006) · Vaccine · doi:10.1016/j.vaccine.2005.08.105 · Cited by 1,064
Gavazzi, G., & Krause, K.-H. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00437-1 · Cited by 990
Walston, J. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.20.2333 · Cited by 940
A program to prevent functional decline in physically frail, elderly persons who live at home
Gill, T. M., Baker, D. I., Gottschalk, M., Peduzzi, P. N., Allore, H., & Byers, A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020423 · Cited by 871
Cited by
Items 101–200 of 268
How to: prophylactic interventions for prevention of Clostridioides difficile infection
Reigadas, E., van Prehn, J., Falcone, M., Fitzpatrick, F., Vehreschild, M. J. G. T., Kuijper, E. J., & Bouza, E. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.06.037 · Cited by 30
Schoffelen, T., Herremans, T., Sprong, T., Nabuurs-Franssen, M. H., Wever, P. C., Joosten, L. A. B., Netea, M. G., van der Meer, J. W. M., Bijlmer, H. A., & van Deuren, M. (2013) · Journal of Infection · doi:10.1016/j.jinf.2013.08.008 · Cited by 29
Epps, P. V., Tumpey, T. M., Pearce, M. B., Golding, H., Higgins, P. A., Hornick, T. R., Burant, C. J., Wilson, B. M., Banks, R. E., Gravenstein, S., et al. (2017) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00498-16 · Cited by 31
Andrew, M. K., Gîlca, V., Waite, N. M., & Pereira, J. A. (2019) · BMC Geriatrics · doi:10.1186/s12877-019-1180-5 · Cited by 29
Maggi, S. (2010) · Expert Review of Vaccines · doi:10.1586/erv.10.26 · Cited by 27
Dotsey, E. Y., Ushach, I., Pone, E. J., Nakajima, R., Jasinskas, A., Argueta, D. A., Dillon, A., DiPatrizio, N. V., Davies, H., Zlotnik, A., et al. (2017) · Scientific Reports · doi:10.1038/srep42584 · Cited by 28
Zlamy, M., Würzner, R., Holzmann, H., Kloss‐Brandstätter, A., Jeller, V., Zimmerhackl, L. B., & Prelog, M. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.10.002 · Cited by 27
Safety Review: Squalene and Thimerosal in Vaccines
Montana, M., Verhaeghe, P., Castera‐Ducros, C., Terme, T., Vanelle, P., & Rathelot, P. (2010) · Therapies · doi:10.2515/therapie/2010069 · Cited by 27
Sierra‐Cruz, M., Miguéns‐Gómez, A., Grau‐Bové, C., Rodríguez‐Gallego, E., Blay, M., Pinent, M., Ardèvol, A., Terra, X., & Beltrán‐Debón, R. (2021) · Nutrients · doi:10.3390/nu13062059 · Cited by 27
Probiotics: beneficial factors of the defence system
Antoine, J. M. (2010) · Proceedings of The Nutrition Society · doi:10.1017/s0029665110001692 · Cited by 31
Lee, N., Shin, M. S., Kang, K. S., Yoo, S. A., Mohanty, S., Montgomery, R. R., Shaw, A. C., & Kang, I. (2014) · Clinical Immunology · doi:10.1016/j.clim.2014.03.003 · Cited by 28
Ebersole, J. L., Kirakodu, S. S., Novak, M. J., Orraca, L., González‐Martínez, J., Cunningham, L. L., Thomas, M. V., Stromberg, A. J., Pandruvada, S. N. M., & González, O. A. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00272 · Cited by 28
Hassouneh, F., López-Sejas, N., Campos, C., Sánchez-Correa, B., Tarazona, R., Solana, R., & Pera, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00649 · Cited by 27
Self-citationSeroprevalence and durability of rubella virus antibodies in a highly immunized population
Crooke, S. N., Haralambieva, I. H., Grill, D. E., Ovsyannikova, I. G., Kennedy, R. B., & Poland, G. A. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.05.049 · Cited by 26
Implication of Aging Related Chronic Neuroinflammation on COVID-19 Pandemic
Bossù, P., Toppi, E., Sterbini, V., & Spalletta, G. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10030102 · Cited by 27
Boikos, C., Imran, M., Nguyen, V. H., Ducruet, T., Sylvester, G. C., & Mansi, J. A. (2021) · Vaccines · doi:10.3390/vaccines9080862 · Cited by 26
McErlean, G., Gilroy, N. M., Brice, L., Kabir, M., Gottlieb, D. J., Huang, G., Hogg, M., Brown, L., Greenwood, M. J., Larsen, S. R., et al. (2018) · Transplant Infectious Disease · doi:10.1111/tid.13043 · Cited by 25
Camilloni, B., Basileo, M., Martino, A. D., Donatelli, I., & Iorio, A. M. (2014) · Immunity & Ageing · doi:10.1186/1742-4933-11-10 · Cited by 24
Self-citationNon-genetic Heterogeneity of Macrophages in Diseases—A Medical Perspective
Gessain, G., Blériot, C., & Ginhoux, F. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.613116 · Cited by 25
Lang, P.-O., Mitchell, W. A., Govind, S., & Aspinall, R. (2011) · Journal of Immunological Methods · doi:10.1016/j.jim.2011.05.002 · Cited by 23
Chou, C., Mohanty, S., Kang, H. A., Kong, L., Ávila-Pacheco, J., Joshi, S. R., Ueda, I., Devine, L., Raddassi, K., Pierce, K. A., et al. (2022) · Aging Cell · doi:10.1111/acel.13682 · Cited by 23
Prevalence and titers of yellow fever virus neutralizing antibodies in previously vaccinated adults
Miyaji, K. T., Avelino‐Silva, V. I., Simões, M., Freire, M. D. S., de Medeiros, C. R., Braga, P. E., Neves, M. A. A., Lopes, M. H., Kallas, E. G., & Sartori, A. M. C. (2017) · Revista do Instituto de Medicina Tropical de São Paulo · doi:10.1590/s1678-9946201759002 · Cited by 23
Khatami, M. (2018) · Clinical and Translational Medicine · doi:10.1186/s40169-018-0193-6 · Cited by 25
Life course vaccination and healthy aging
Gusmano, M. K., & Michel, J. (2009) · Aging Clinical and Experimental Research · doi:10.1007/bf03324907 · Cited by 23
Self-citationMalaria vaccines: looking back and lessons learnt
Lorenz, V., & Karanis, P. (2011) · Asian Pacific Journal of Tropical Biomedicine · doi:10.1016/s2221-1691(11)60072-5 · Cited by 25
Aging mitigates the severity of obesity-associated metabolic sequelae in a gender independent manner
Moreno‐Fernandez, M. E., Sharma, V., Stankiewicz, T. E., Oates, J. R., Doll, J., Damen, M. S. M. A., Almanan, M., Chougnet, C. A., Hildeman, D. A., & Divanovic, S. (2021) · Nutrition and Diabetes · doi:10.1038/s41387-021-00157-0 · Cited by 22
Kannan, S., Kurupati, R. K., Doyle, S. A., Freeman, G. J., Schmader, K. E., & Ertl, H. C. J. (2015) · Oncotarget · doi:10.18632/oncotarget.4597 · Cited by 23
Vaccination of healthcare personnel: Spotlight on groups with underlying conditions
Wicker, S., Seale, H., von Gierke, L., & Maltezou, H. C. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.05.070 · Cited by 21
Pawelec, G., Derhovanessian, E., & Larbi, A. (2010) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2010.04.002 · Cited by 21
Self-citationHansen, C. B., Jarlhelt, I., Hasselbalch, R. B., Hamm, S. R., Fogh, K., Pries‐Heje, M. M., Møller, D. L., Heftdal, L. D., Pérez‐Alós, L., Sørensen, E., et al. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13366 · Cited by 20
Characterization of MHC-II antigen presentation by B cells and monocytes from older individuals
Clark, H. L., Banks, R. E., Jones, L., Hornick, T. R., Higgins, P. A., Burant, C. J., & Canaday, D. H. (2012) · Clinical Immunology · doi:10.1016/j.clim.2012.06.005 · Cited by 23
TLR-2 independent recognition of Mycobacterium tuberculosis by CD11c+ pulmonary cells from old mice
Rottinghaus, E. K., Vesosky, B., & Turner, J. (2010) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2010.05.006 · Cited by 21
Keeping the memory of influenza viruses
Combadière, B., Sibéril, S., & Duffy, D. (2010) · Pathologie Biologie · doi:10.1016/j.patbio.2010.01.010 · Cited by 20
Du, X., Wang, J., Niu, X., Smith, D. E., Wu, D., & Meydani, S. N. (2013) · Journal of Nutrition · doi:10.3945/jn.113.183566 · Cited by 22
Important roles of Akt PKB signaling in the aging process
Blough, E. R. (2010) · Frontiers in Bioscience-Scholar · doi:10.2741/s125 · Cited by 23
Mandating influenza vaccination for healthcare workers
Sullivan, S. J., Jacobson, R. M., & Poland, G. A. (2009) · Expert Review of Vaccines · doi:10.1586/erv.09.118 · Cited by 20
Lymph node size as a predictor of lymphatic staging in colonic cancer
Sloothaak, D., Grewal, S. S., Doornewaard, H., van Duijvendijk, P., Tanis, P. J., Bemelman, W. A., van der Zaag, E. S., & Buskens, C. J. (2014) · British journal of surgery · doi:10.1002/bjs.9451 · Cited by 21
Baladi, A., Tafenzi, H. A., Zouiten, O., Afani, L., Essâdi, I., Fadli, M. E., & Belbaraka, R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052120 · Cited by 21
Rosenstein, M. D., de Visser, A. W., Visser, L. G., & Roukens, A. H. E. (2021) · Journal of Travel Medicine · doi:10.1093/jtm/taab126 · Cited by 19
Joshi, S. R., Shaw, A. C., & Quagliarello, V. (2009) · PubMed Central · Cited by 19
Vassilieva, E. V., Wang, S., Li, S., Prausnitz, M. R., & Compans, R. W. (2017) · Scientific Reports · doi:10.1038/s41598-017-18140-0 · Cited by 19
Bengnér, M., Béziat, V., Ernerudh, J., Nilsson, B.-O., Löfgren, S., Wikby, A., Malmberg, K., & Strindhall, J. (2013) · AGE · doi:10.1007/s11357-013-9587-y · Cited by 19
Kiecolt‐Glaser, J. K., Renna, M. E., Peng, J., Sheridan, J. F., Lustberg, M. B., Ramaswamy, B., Wesolowski, R., VanDeusen, J. B., Williams, N. O., Sardesai, S. D., et al. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.03.019 · Cited by 18
Immunosenescence: implications for vaccination programs in the elderly
Bowdish, D. M. E., Loukov, D., & Naidoo, A. (2015) · Vaccine Development and Therapy · doi:10.2147/vdt.s63888 · Cited by 23
The BNT162b2 mRNA vaccine demonstrates reduced age-associated TH1 support in vitro and in vivo
Brook, B., Fatou, B., Barman, S., Barman, S., Sweitzer, C., Bosco, A.-N., Sherman, A., Baden, L., Morrocchi, E., Sánchez‐Schmitz, G., et al. (2024) · iScience · doi:10.1016/j.isci.2024.111055 · Cited by 16
Hwang, Y. G., Hsu, H., Lim, F. C., Wu, Q., Yang, P., Fisher, G., Hunter, G. R., & Mountz, J. D. (2013) · Advances in Aging Research · doi:10.4236/aar.2013.22010 · Cited by 20
Effect of Cytomegalovirus (CMV) and Ageing on T-Bet and Eomes Expression on T-Cell Subsets
Hassouneh, F., López-Sejas, N., Campos, C., Sánchez-Correa, B., Tarazona, R., Pera, A., & Solana, R. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071391 · Cited by 16
Self-citationSpontaneous and induced platelet aggregation in apparently healthy subjects in relation to age
Kuhnla, A., Reinthaler, M., Braune, S., Maier, A., Pindur, G., Lendlein, A., & Jung, F. (2019) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-199006 · Cited by 17
Pachnio, A., Begum, J., Fox, A., & Moss, P. A. H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125287 · Cited by 14
Aging, nutrition and immunity – their relationship and interaction
Alam, I., & Pawelec, G. (2012) · Nutrition and Aging · doi:10.3233/nua-130013 · Cited by 16
Self-citationPereira, J. A., Gîlca, V., Waite, N. M., & Andrew, M. K. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1520580 · Cited by 14
Gardner, J. K., Mamotte, C. D. S., McGonigle, T., Dye, D. E., Jackaman, C., & Nelson, D. J. (2014) · Immunity & Ageing · doi:10.1186/1742-4933-11-11 · Cited by 14
Basophil, Eosinophil, and Neutrophil Functions in the Elderly
Uciechowski, P., & Rink, L. (2013) · Springer eBooks · doi:10.1007/978-3-642-39495-9_5 · Cited by 13
Veronese, N., & Barbagallo, M. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101373 · Cited by 15
Perspectives on Immunotherapy in Prostate Cancer and Solid Tumors: Where Is the Future?
Snyder, A., Tepper, J. E., & Slovin, S. F. (2013) · Seminars in Oncology · doi:10.1053/j.seminoncol.2013.04.009 · Cited by 13
Chan, T., Hung, I. F., Chan, K., Li, C. P.-Y., Li, P. T.-W., Luk, J. K.-H., Chu, L., & Chan, F. H.-W. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2014.05.002 · Cited by 13
Kunze, U. (2015) · Ticks and Tick-borne Diseases · doi:10.1016/j.ttbdis.2015.04.005 · Cited by 12
Jeon, Y., Han, S.-I., & Park, E. J. (2018) · Annals of General Psychiatry · doi:10.1186/s12991-018-0201-7 · Cited by 12
Nilsson, L. M., Andersson, C., Kastbom, L., & Sjödahl, R. I. (2022) · Primary Health Care Research & Development · doi:10.1017/s1463423622000640 · Cited by 12
Resisting Moral Permissiveness about Vaccine Refusal
Navin, M. C. (2013) · PhilPapers (PhilPapers Foundation) · Cited by 16
Vo, T. K. D., Godard, P., de Saint‐Hubert, M., Morrhaye, G., Swine, C., Geenen, V. G., Martens, H., Debacq‐Chainiaux, F., & Toussaint, O. (2010) · Immunity & Ageing · doi:10.1186/1742-4933-7-9 · Cited by 12
Paccalin, M., Weinberger, B., Nicolas, J., Damme, P. V., & Mégard, Y. (2010) · European Geriatric Medicine · doi:10.1016/j.eurger.2010.03.004 · Cited by 11
Papazisis, G., Topalidou, X., Gioula, G., González, P. A., Bueno, S. M., & Kalergis, A. M. (2024) · Vaccines · doi:10.3390/vaccines12040353 · Cited by 13
Effects of human Toll-like receptor 1 polymorphisms on ageing
Uciechowski, P., Oellig, E. M., Mariani, E., Malavolta, M., Mocchegiani, E., & Rink, L. (2013) · Immunity & Ageing · doi:10.1186/1742-4933-10-4 · Cited by 12
Sherman, A. C., Desjardins, M., & Baden, L. R. (2021) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2021.10.008 · Cited by 11
E47 retroviral rescue of intrinsic B‐cell defects in senescent mice
Landin, A. M., Frasca, D., Harrison, P. T., Scallan, M. F., Riley, R. L., & Blomberg, B. B. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2011.00673.x · Cited by 11
T. cruzi infection among aged rats: Melatonin as a promising therapeutic molecule
Brazão, V., Santello, F. H., Colato, R. P., & Júnior, J. C. D. P. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.110922 · Cited by 12
Imran, M., Mills, C. W., McDermott, K. W., Dean, A., Bogdanov, A., McGovern, I., & Haag, M. D. M. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofae459 · Cited by 10
Immunseneszenz: Bestandsaufnahme und molekulare Grundlagen
Peters, T. (2011) · Der Hautarzt · doi:10.1007/s00105-011-2134-9 · Cited by 10
Rodrigues‐Santos, P., López-Sejas, N., Almeida, J. S., Ruzickova, L., Couceiro, P., Alves, V., Campos, C., Alonso, C., Tarazona, R., Freitas-Tavares, P., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02587 · Cited by 12
Self-citationThe Potential Beneficial Effects of Drugs on the Immune Response to Vaccination
Liu, W. M., & Dalgleish, A. G. (2012) · Seminars in Oncology · doi:10.1053/j.seminoncol.2012.02.012 · Cited by 10
Sudduth, E. R., Ruiz, A. L., Trautmann-Rodriguez, M., & Fromen, C. A. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02743-7 · Cited by 9
Camboni, M., Wang, C.-M., Miranda, C. J., Yoon, J. H., Xu, R., Zygmunt, D. A., Kaspar, B. K., & Martin, P. T. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.09.001 · Cited by 11
Immunological Treatment Options for Locoregionally Advanced Head and Neck Squamous Cell Carcinoma
Schutt, C. A., Bumm, K., Mirandola, L., Bernardini, G., Cunha, N. D., Tijani, L., Nguyen, D. D. T., Cordero, J., Jenkins, M., Cobos, E., et al. (2012) · International Reviews of Immunology · doi:10.3109/08830185.2011.637253 · Cited by 9
Nace, D. A., Handler, S. M., Hoffman, E. L., & Perera, S. (2012) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2012.08.016 · Cited by 9
Kim, J. I., Stott, R. T., Soohoo, J., Lee, K. M., Zhao, G., Yeh, H., Deng, S., & Markmann, J. F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082856 · Cited by 9
Imran, M., Mills, C., McDermott, K. W., Dean, A., Bogdanov, A., McGovern, I., & Haag, M. D. M. (2024) · Vaccine · doi:10.1016/j.vaccine.2024.126316 · Cited by 8
Skull base aspergillosis in an immunocompetent elderly man with early response to steroid
Sarkar, P., Price, C., Fish, M., & Bennetto, L. (2018) · BMJ Case Reports · doi:10.1136/bcr-2018-226998 · Cited by 8
High-dose trivalent influenza vaccine: safety and immunogenicity
de Lejarazu, R. O., Martinón‐Torres, F., de Miguel, Á. G., Díez‐Domingo, J., & Margüello, E. R. (2020) · Revista Española de Quimioterapia · doi:10.37201/req/110.2020 · Cited by 9
Immunosenescence and its potential modulation: lessons from mouse models
Boldizsár, F., Mikecz, K., & Glant, T. T. (2010) · Expert Review of Clinical Immunology · doi:10.1586/eci.10.16 · Cited by 8
Franco-Leyva, T., Torres, O. H., Saez, M. E., Boera-Carnicero, G., Santos, Á., Clotet, S., Albert-Jares, D., El-Ebiary, Y., Agustí-Martí, M., Casademont, J., et al. (2022) · Journal of Leukocyte Biology · doi:10.1002/jlb.5ma0422-370r · Cited by 7
Woods, J., Iuliano-Burns, S., & Walker, K. Z. (2013) · Immunity & Ageing · doi:10.1186/1742-4933-10-32 · Cited by 8
Raso, V., Natale, V. M., Duarte, A. J. D. S., Greve, J. M. D., & Shephard, R. J. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.01.012 · Cited by 7
Liu, L. A., & Rando, T. A. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-378638-8.00006-3 · Cited by 8
Vaccination Strategies and Research Gaps in Hepatitis E Virus for Special Populations
Wang, M., Duan, B., Liu, M., Zhang, Y., Wu, F., Li, G., & Ouyang, Y. (2025) · Vaccines · doi:10.3390/vaccines13060621 · Cited by 6
High-dose trivalent influenza vaccine. Efficacy and effectiveness
de Miguel, Á. G., Margüello, E. R., Díez‐Domingo, J., de Lejarazu, R. O., Martinón‐Torres, F., & Departamento de Medicina Preventiva y Salud Pública, U. R. J. C. (2020) · Revista Española de Quimioterapia · doi:10.37201/req/043.2020 · Cited by 6
Horie, K., Hossain, M. S., Kim, Y., Ishida, A., Kon, R., Yamatsu, A., Kishima, M., Nishikimi, T., & Kim, M. (2021) · Journal of Food Science · doi:10.1111/1750-3841.15675 · Cited by 6
Evaluation on the implementation of respiratory protection measures in old age homes
Lee, D., Yu, D. S. F., Ip, M., & Tang, J. Y. ‐. (2017) · Clinical Interventions in Aging · doi:10.2147/cia.s142522 · Cited by 6
Khatami, M. (2017) · Springer eBooks · doi:10.1007/978-3-319-66475-0_3 · Cited by 6
Fragilité et infection chez le sujet âgé : quelles relations ?
Mazière, S., Gavazzi, G., & Paccalin, M. (2012) · Les cahiers de l année gérontologique · doi:10.1007/s12612-012-0255-4 · Cited by 7
Introduction to Ageing of the Adaptive Immune System
Müller, L., & Pawelec, G. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4776-4_2 · Cited by 7
Self-citationHaley, G. E., Urbanski, H. F., Kohama, S., Messaoudi, I., & Raber, J. (2011) · European Geriatric Medicine · doi:10.1016/j.eurger.2011.01.002 · Cited by 6
Othman, A. A., & Albargy, H. A. (2025) · Annals of Saudi Medicine · doi:10.5144/0256-4947.2025.361 · Cited by 5
The immune system during ageing
Müller, L., Pawelec, G., & Derhovanessian, E. (2013) · Elsevier eBooks · doi:10.1533/9780857095749.4.631 · Cited by 7
Self-citationAge-associated defect in ADCC response to COVID-19 vaccine
Sievers, B. L., Altaf, M., Cheng, M. T. K., Kamelian, K., Cormie, C., Bradley, J. R., Baker, S. G., Graves, B., Stark, H., Hein, S., et al. (2025) · npj Vaccines · doi:10.1038/s41541-025-01196-9 · Cited by 6
Shivshankar, P. (2012) · ISRN Inflammation · doi:10.5402/2012/267101 · Cited by 4
Immunseneszenz. Bestandsaufnahme und molekulare Grundlagen
Peters, T. (2011) · Der Hautarzt · Cited by 6
Tribin, F. E., Williams, E., Testamarck, V., Carreño, J. M., Bielak, D. A., Yellin, T., Krammer, F., Hoffer, M. E., Pallikkuth, S., & Pahwa, S. G. (2024) · PLoS ONE · doi:10.1371/journal.pone.0292566 · Cited by 4
Sharma, R., Ahlm, C., Østergaard, L. J., Dowell, A., Tran, C., Thomas, S., & Eymin, C. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1019187 · Cited by 6
Khatami, M. (2020) · Clinical and Translational Medicine · doi:10.1002/ctm2.215 · Cited by 5
Retracted
Metadata
- Authors
- Grubeck-Loebenstein, B., Della Bella, S., Iorio, A. M., Michel, J.-P., Pawelec, G., & Solana, R.
- Affiliations
- University of Perugia (IT)
- University Hospital of Geneva (CH)
- University of Tübingen (DE)
- University of Córdoba (ES)
- Venue
- Aging Clinical and Experimental Research
- Published
- 2009-06
- Volume
- 21
- Issue
- 3
- Pages
- 201-209
- ISSN
- 1594-0667 (ISSN-L)
- 1720-8319
- OpenAlex
- W2122455470
- Cited by
- 269
- References
- 89
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 15 · 2023: 2 · 2022: 9 · 2021: 17 · 2020: 13 · 2019: 15 · 2018: 10 · 2017: 20 · 2016: 15 · 2015: 17 · 2014: 14 · 2013: 25 · 2012: 24
- FWCI
- 2.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Aging Clinical and Experimental Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Sanofi Pasteur
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- immunosenescence, vaccine failure, older adults, frailty, NK cell cytotoxicity, dendritic cells, cytomegalovirus, vaccine response, seroprotection, influenza vaccination, high-dose vaccine, infection susceptibility
- MeSH terms
- Aged, Aging, B-Lymphocytes, Dendritic Cells, Humans, Immune System, Immunity, Innate, T-Lymphocytes, Vaccination
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.